Geriatric medicine Archives - Page 4 of 7

Podcasts

MCI, bio markers and medications

Videos

The role of a medical food (Souvenaid) in the management of patients with early Alzheimer’s disease including mild cognitive impairment

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

Clinical Articles

New sarcopenia algorithm for GP

Experts have devised a new algorithm to help GPs identify poor muscle health before sarcopenia develops...

Podcasts

The new imperative for healthy ageing

Dr Leon Geffen discusses new health conditions associated with the ageing population and resources to get GPs up to speed on the latest recommendations.

Podcasts

Frailty – Management tips for general practice

Welcome to the 45Up podcast. Join Dr Marita Long as she discusses healthy aging with leading experts, so GPs and healthcare professionals can better support patients to increase their health span as opposed to just their life span.

Clinical Articles

Could the shingles vaccine lower risk of dementia?

A recent study has suggested Shingrix may delay the onset of dementia...

Podcasts

Maintaining muscles of independence – Sarcopenia screening & management – Lecture

Dr Anita Munoz provides a practical framework to help GPs identify and assess older patients with or at risk of sarcopenia and muscle weakness.

Learning Modules

RSV and the Heart

Healthed brings together four leading experts in infectious disease, cardiology, geriatrics and diabetes for a lively, authoritative, cross disciplinary discussion.

Podcasts

Mild Cognitive Impairment – What Can GPs do About it? – Lecture

Dr Mark Hohenberg explains that early intervention often can help.

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Videos

ENSURE – The role of early intervention in muscle health

In this Product Explainer Geriatrician A/Prof Solomon Yu explains the importance of integrating muscle health screening, diagnosis and management in routine clinical practice, and the role of early intervention including HMB enriched oral nutritional supplementation for preventing and reversing sarcopenia.

Clinical Articles

Shingrix FAQ

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

Geriatric medicine

MCI, bio markers and medications

The role of a medical food (Souvenaid) in the management of patients with early Alzheimer’s disease including mild cognitive impairment

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

New sarcopenia algorithm for GP

Experts have devised a new algorithm to help GPs identify poor muscle health before sarcopenia develops...

The new imperative for healthy ageing

Dr Leon Geffen discusses new health conditions associated with the ageing population and resources to get GPs up to speed on the latest recommendations.

Frailty – Management tips for general practice

Welcome to the 45Up podcast. Join Dr Marita Long as she discusses healthy aging with leading experts, so GPs and healthcare professionals can better support patients to increase their health span as opposed to just their life span.

Could the shingles vaccine lower risk of dementia?

A recent study has suggested Shingrix may delay the onset of dementia...

Maintaining muscles of independence – Sarcopenia screening & management – Lecture

Dr Anita Munoz provides a practical framework to help GPs identify and assess older patients with or at risk of sarcopenia and muscle weakness.

RSV and the Heart

Healthed brings together four leading experts in infectious disease, cardiology, geriatrics and diabetes for a lively, authoritative, cross disciplinary discussion.

Mild Cognitive Impairment – What Can GPs do About it? – Lecture

Dr Mark Hohenberg explains that early intervention often can help.

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

ENSURE – The role of early intervention in muscle health

Shingrix FAQ

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Geriatric medicine

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

Experts have devised a new algorithm to help GPs identify poor muscle health before sarcopenia develops...

Dr Leon Geffen discusses new health conditions associated with the ageing population and resources to get GPs up to speed on the latest recommendations.

Welcome to the 45Up podcast. Join Dr Marita Long as she discusses healthy aging with leading experts, so GPs and healthcare professionals can better support patients to increase their health span as opposed to just their life span.

A recent study has suggested Shingrix may delay the onset of dementia...

Dr Anita Munoz provides a practical framework to help GPs identify and assess older patients with or at risk of sarcopenia and muscle weakness.

Healthed brings together four leading experts in infectious disease, cardiology, geriatrics and diabetes for a lively, authoritative, cross disciplinary discussion.

Dr Mark Hohenberg explains that early intervention often can help.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹